Invesco Ltd. remains a Buy with a new price target after strong Q3 '25 results. IVZ delivered record organic growth, robust ETF inflows, and improved efficiency, but faces declining fee realization rates and industry underperformance risks. While upside is now slimmer, IVZ offers a 3.5%+ yield, solid credit, and limited alternatives in an overvalued financial sector.
ATLANTA , Nov. 11, 2025 /PRNewswire/ -- Invesco Ltd. (NYSE: IVZ)1, a leading global asset management firm announced today preliminary month-end assets under management (AUM) of $2,166.6 billion, an increase of 2.0% versus previous month-end.
Invesco Announces Third Quarter Diluted EPS of $0.66; Adjusted Diluted EPS(1) of $0.61 ATLANTA , Oct. 28, 2025 /PRNewswire/ -- Invesco Ltd. (NYSE: IVZ) today reported financial results for the three months ended September 30, 2025.
We purchased several new fund holdings across various sectors. Sempra has been shifting its strategic focus from its highly regulated California operations to its growing presence in Texas. Regeneron in our view has a strong balance sheet and a robust product pipeline.
For income investors with a smaller amount of new money to put to work, going for some of the lower-priced stocks could make a lot of sense, especially if one's brokerage doesn't allow for the purchase of partial shares.
ATLANTA , Oct. 9, 2025 /PRNewswire/ -- Invesco Ltd. (NYSE: IVZ)1 today reported preliminary month-end assets under management (AUM) of $2,124.8 billion, an increase of 3.0% versus previous month-end.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.